EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric glycopeptide use in neutropenic fever. (2022). Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022039. https://doi.org/10.4084/MJHID.2022.039